Cite
MLA Citation
Arpit Rao and Richard Lauer. “Phase II Study of Sorafenib and Bortezomib for First-Line Treatment of Metastatic or Unresectable Renal Cell Carcinoma.” Oncologist, vol. 20, 2015, pp. 370–371. http://access.bl.uk/ark:/81055/vdc_100151235284.0x000028